EP3333161
2-(2,4,5-Setið-anilínó)pýrimídínafleiður sem EGFR stillar sem eru nytsamlegir við meðhöndlun á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.7.2012EP published:
19.2.2020EP application number:
17194307.9
EP translation filed:
27.4.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
24.7.2032Expiry date:
24.7.2026Next due date:
31.7.2026
Title:
2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER
Timeline
Today
25.7.2012EP application
19.2.2020EP Publication
27.4.2020Translation submitted
15.5.2020Registration published
24.7.2026Expires
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
BUTTERWORTH, SamAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
WARD, Richard, AndrewAddress:
Cambridge, Cambridgeshire CB4 0WG, GB
Name:
FINLAY, Maurice, Raymond, VerschoyleAddress:
Cambridge, Cambridgeshire CB4 0WG, GB
Name:
KADAMBAR, Vasantha, KrishnaAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
CHINTAKUNTLA, Chandrasekhara, ReddyAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
MURUGAN, AndiappanAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
CHUAQUI, Claudio, EdmundoAddress:
Waltham, MA 02451, US
Name:
REDFEARN, Heather, MarieAddress:
Macclesfield, Cheshire SK10 2NA, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161512061 PDate:
27.7.2011Country:
US
Number:
201261591363 PDate:
27.1.2012Country:
US
Classification
Categories:
C07D 401/02, C07D 471/04, A61K 31/506, A61K 31/437, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 3.7.2020
Expires: 24.7.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.6.2021
Expires: 24.7.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.6.2022
Expires: 24.7.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.6.2023
Expires: 24.7.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 6.6.2024
Expires: 24.7.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 9.7.2025
Expires: 24.7.2026
Payer: Árnason Faktor ehf.